These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26753415)

  • 21. Disclosure obligations of the newly public healthcare company: practical strategies for the company and its counsel.
    Horton WW; McFadden FH
    J Health Law; 1999; 32(1):1-38. PubMed ID: 10569844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYTO Innovation: Inspiring and Supporting Innovators in ISAC.
    Holden E; Smith PJ
    Cytometry A; 2019 Apr; 95(4):411-415. PubMed ID: 30882998
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UK government unveils innovation booster.
    Moran N
    Nat Biotechnol; 2012 Feb; 30(2):125. PubMed ID: 22318020
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
    Zakeri K; Narayanan D; Vikram B; Evans G; Coleman CN; Prasanna PGS
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):188-196. PubMed ID: 30583040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Science in Argentina. Where do we go from here?].
    Barañao L
    Medicina (B Aires); 2012; 72(4):339-49. PubMed ID: 22892088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Workshop on Astrobiology: the life science involvement of AAS-I Laben.
    Adami G
    Orig Life Evol Biosph; 2006 Dec; 36(5-6):567-76. PubMed ID: 17171428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Best of both worlds.
    Smaglik P
    Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
    [No Abstract]   [Full Text] [Related]  

  • 30. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is the fair price of innovative therapy?].
    Fischer A; Dewatripont M; Goldman M
    Med Sci (Paris); 2020 Apr; 36(4):389-393. PubMed ID: 32356716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The scientific muscle of Brazil's health biotechnology.
    Ferrer M; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC8-12. PubMed ID: 15583686
    [No Abstract]   [Full Text] [Related]  

  • 33. The frontier of tDCS in psychiatry and the role of new technologies.
    Simon L; Bikson M
    Encephale; 2019 Jun; 45 Suppl 2():S55-S57. PubMed ID: 31088687
    [No Abstract]   [Full Text] [Related]  

  • 34. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 36. [The imminent peril in the law of July the fifth 2011, two years later: the impact on health?].
    Mondoloni A; Buard M; Nargeot J; Vacheron MN
    Encephale; 2014 Dec; 40(6):468-73. PubMed ID: 24703930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investing in neurosurgery innovations: an editorial.
    Krishna C; Natarajan SK; Hopkins LN
    Neurosurgery; 2014 Aug; 61 Suppl 1():135-6. PubMed ID: 25032542
    [No Abstract]   [Full Text] [Related]  

  • 38. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of a grant program for improving health and safety in small and medium companies in Andalusia (Spain)].
    Carrillo Castrillo JA; Onieva Giménez L; Ruiz Frutos C
    Arch Prev Riesgos Labor; 2012; 15(4):185-91. PubMed ID: 23797630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invention and business performance in the tissue-engineering industry.
    Pangarkar N; Hutmacher DW
    Tissue Eng; 2003 Dec; 9(6):1313-22. PubMed ID: 14670118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.